Research from Mass General Brigham indicates that a new olfactory test could help detect the risk of Alzheimer's disease and other neurodegenerative disorders before symptoms manifest. The study involved a cost-effective, noninvasive test where participants assess their ability to identify odors at home. Findings showed that older adults with cognitive impairments performed worse than cognitively healthy individuals. Lead researcher Mark Albers highlights that this method could facilitate earlier treatment and intervention, capitalizing on the relationship between smell and cognitive health.
Researchers from Harvard-affiliated Mass General Brigham have developed a home olfactory test for early detection of Alzheimer's risk, linking diminished smell to cognitive decline.
The aim of the olfactory test is to provide a noninvasive, cost-effective method for early risk identification in neurodegenerative diseases, potentially allowing earlier intervention.
Senior author Mark Albers states that early detection through smell tests could facilitate timely interventions before memory symptoms develop, impacting Alzheimer's treatment.
The Aromha Brain Health Test leverages detection of olfactory dysfunction, exploring its connection to neurodegenerative diseases like Alzheimer's and Parkinson's.
Collection
[
|
...
]